3rd annual conference on Orphan and Nuclear Receptors

Venue: Holiday Inn on the Bay

Location: San Diego, California, United States

Event Date/Time: Oct 06, 2003 End Date/Time: Oct 07, 2003
Registration Date: Oct 06, 2003
Report as Spam


Detailed Agenda available on website.

The application of drugs directed towards known nuclear receptor targets has produced some of the most commercially viable pharmaceuticals. Therefore, research and development has intensified toward identifying new ligands for orphan receptors as well as acquiring a greater understanding of known nuclear receptors and their interactions. As research progresses, additional areas are revealed in which nuclear receptors play an important role, such as metabolic and endocrine pathways, oncology or skin diseases.
This conference provides the latest information on the metabolism of orphan and nuclear receptors along with novel ligands, agonists and ligand screening technologies.

An international assembly of experts highlights the major achievements and challenges on topics such as:
• GPCR targeted libraries
• Biological membrane microarrays
• Chemokine receptors
• Crystal structures of ligand binding domains of PPAR
• PPARg modulators with novel biological activities
• PPAR and LXR in inflammation models
• Novel ligands for LXR and CAR
• Nuclear receptors as oncology targets
• The therapeutic potential of ERR
• Assay technologies for FXR antagonists

Pre-Conference Workshop

G Protein Coupled Receptors - Opportunities in Drug Development